Jefferies Group LLC Novartis Ag Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $487,340 - $682,772	-6,896 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $6.39 Million - $7.22 Million	-75,713 Reduced 91.65%	6,896 $653,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $4.1 Million - $4.64 Million	63,229 Added 326.26%	82,609 $6.24 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $807,725 - $965,621	11,475 Added 145.16%	19,380 $1.57 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $571,768 - $613,744	7,905	7,905 $664,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.